| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.45 | 0.1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |